Steinberg, Julia
Chan, Priscilla
Hogden, Emily
Tiernan, Gabriella
Morrow, April
Kang, Yoon-Jung
He, Emily
Venchiarutti, Rebecca
Titterton, Leanna
Sankey, Lucien
Pearn, Amy
Nichols, Cassandra
McKay, Skye
Hayward, Anne
Egoroff, Natasha
Engel, Alexander
Gibbs, Peter
Goodwin, Annabel
Harris, Marion
Kench, James G
Pachter, Nicholas
Parkinson, Bonny
Pockney, Peter
Ragunathan, Abiramy
Smyth, Courtney
Solomon, Michael
Steffens, Daniel
Toh, James Wei Tatt
Wallace, Marina
Canfell, Karen
Gill, Anthony
Macrae, Finlay
Tucker, Kathy
Taylor, Natalie
Funding for this research was provided by:
Cancer Institute NSW (2017/CDF005)
Cancer Australia (1123924)
Article History
Received: 2 February 2022
Accepted: 10 April 2022
First Online: 4 May 2022
Declarations
:
: Ethics approval for this study was granted by the Royal Prince Alfred Hospital Human Research Ethics Committee (reference HREC/17/RPAH/542); the ethics committee approved a waiver of consent from individual patients to collect the clinical data. Site-specific governance approval was obtained from each hospital site.
: Not applicable.
: KC is co-PI of unrelated investigator-initiated trial of cervical screening in Australia (‘Compass’) conducted by the Victorian Cytology Service, which has received funding contribution from Roche Molecular Systems and Ventana, USA. The other authors declare no potential conflicts of interest.